🔎 Trials Near Me

Home › Cancro colorettale › California

Studi clinici su Cancro colorettale nello stato di California

137 studi su Cancro colorettale cercano partecipanti presso sedi nello stato di California.

Città nello stato di California

Testo ufficiale dello studio (inglese)

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

  • Tower Cancer Research Foundation, Beverly Hills
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • Cedars-Sinai Medical Center, Los Angeles
  • e altri 1
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05673148

Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

  • Jennifer Moreno Department of Veterans Affairs Medical Cneter, San Diego
  • Kaiser Permanente Northern California, Walnut Creek
In reclutamento
Età da 65 a 82 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05612347

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • University of San Diego Moores Cancer Center, La Jolla
  • UCLA Jonsson Comprehensive Cancer Center, Los Angeles
  • USC Norris Comprehensive Cancer Center, Los Angeles
In reclutamentoFase 1/2
Età 12 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT04585750

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
  • PCR Oncology, Arroyo Grande
  • AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
  • e altri 20
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 40 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05334069

Family Communications After Genetic Testing

  • Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank
  • Marshall Cancer Center, Cameron Park
  • e altri 17
In reclutamentoVolontari sani benvenuti
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT07143487

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

  • Exelixis Clinical Site #59, Santa Barbara
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT05176483

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

  • City of Hope Comprehensive Cancer Center, Duarte
  • University of California Los Angeles, Los Angeles
  • University of California San Diego Moores Cancer Center, San Diego
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06625775

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

  • The Oncology Institute of Hope and Innovation, Cerritos
  • Ellison Medical Institute, Los Angeles
  • Valkyrie Clinical Trials, Los Angeles
  • e altri 3
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT06324357

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

  • ALX Center 9, La Jolla
  • ALX Center 11, Santa Monica
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07085091

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

  • Research Site, Duarte
  • Research Site, Los Angeles
  • Research Site, Newport Beach
  • e altri 1
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 set 2026 · NCT05877599

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

  • START Los Angeles, Los Angeles
  • Valkyrie Clinical Trials (contact for more locations), Los Angeles
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 set 2026 · NCT07659795

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 set 2026 · NCT05803382

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

  • City of Hope National Medical Center /ID# 270255, Duarte
  • UCLA - Santa Monica /ID# 270621, Santa Monica
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT06820463

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  • UCSF at Berkeley Outpatient Center, Berkeley
  • Alta Bates Summit Medical Center-Herrick Campus Comprehensive Cancer Center, Berkeley
  • UCSD Medical Center - Encinitas, Encinitas
  • e altri 21
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07222800

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
  • USC Norris Comprehensive Cancer Center, Los Angeles
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT05482893

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

  • UCLA ( Site 0317), Los Angeles
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06428409

A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer

  • University of California, Los Angeles UCLA, Los Angeles
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT05379595

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

  • Research Site, Duarte
  • Research Site, Los Angeles
  • Research Site, Newport Beach
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06218914

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • University of California San Diego, La Jolla
  • Stanford University, Palo Alto
  • UCLA Medical Center, Santa Monica
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT04981119

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

  • City of Hope Cancer Center, Duarte
  • City of Hope at Irvine Lennar, Irvine
  • START Los Angeles, Los Angeles
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06004245

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

  • CBCC Global Research, Bakersfield
  • Los Angeles Cancer Network, Glendale
  • Cancer and Blood Specialty Clinic, Los Alamitos
  • e altri 4
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06750094

Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial

  • City of Hope Comprehensive Cancer Center, Duarte
  • City of Hope at Irvine Lennar, Irvine
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07271355

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

  • CBCC Global Research, Bakersfield
  • Los Angeles Cancer Network, Glendale
  • Cancer and Blood Specialty Clinic, Los Alamitos
  • e altri 4
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06662786

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

  • Kivu Trial Site, Santa Monica
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 set 2026 · NCT07229313

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

  • Precision NextGen Oncology, Beverly Hills
  • OPN Healthcare, Inc, Glendale
  • University of Southern California, Los Angeles
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06047379

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

  • USC/Norris Comprehensive Cancer Center, Los Angeles
  • University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
  • Local Institution - 0317, San Francisco
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT07221357

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

  • Research Site, Los Angeles
  • Research Site, Santa Rosa
In reclutamentoFase 2
Età da 18 a 130 · Tutti i sessi · Aggiornato il 23 set 2026 · NCT05489211

Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

  • UC Irvine Health Cancer Center-Newport, Costa Mesa
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • USC / Norris Comprehensive Cancer Center, Los Angeles
  • e altri 1
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT06102902

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • UC IRVINE Health, Orange
  • UC Davis Comprehensive Cancer Center, Sacramento
  • Stanford Cancer Institute, Stanford
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06128551

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

  • City of Hope, Duarte
  • University of California, Los Angeles (UCLA), Santa Monica
  • Stanford University Medical Center, Stanford
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07114601

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

  • UC San Diego Moores Cancer Center, La Jolla
  • Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
  • UCLA Hematology/Oncology- Santa Monica, Los Angeles
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06445062

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

  • Hoag Memorial Hospital Presbyterian, Newport Beach
  • Stanford University Medical Center, Stanford
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07213791

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  • The Angeles clinic - A cedars SINAI AFFILIATE, Los Angeles
  • USC Norris Comprehensive Cancer Center, Los Angeles
  • University of California, San Francisco (UCSF), San Francisco
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 set 2026 · NCT05786924

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

  • Memorial Care Orange Coast Medical Center, Fountain Valley
  • Providence Medical Foundation, Fullerton
  • Cancer & Blood Research Center, Los Alamitos
  • e altri 1
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 set 2026 · NCT07284849

A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

  • City of Hope Comprehensive Cancer Center, Duarte
  • Cedars-Sinai Medical Center, Los Angeles
  • UCLA, Los Angeles
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 11 set 2026 · NCT04929223

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

  • USC/Norris Comprehensive Cancer Center, Los Angeles
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 set 2026 · NCT06440005

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

  • Clinical Study Site, Beverly Hills
  • Clinical Study Site, Beverly Hills
  • Clinical Study Site, Cerritos
  • e altri 21
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT07228832

Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients

  • Stanford University, Palo Alto
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT07403981

Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.